Several IL-1 signalling inhibitors have been studied for their effectiveness against COVID-19, including a human IL-1RA (also known as anakinra), a soluble decoy receptor and a neutralizing monoclonal antibody.35 The gene discussed is IL1B; the disease is COVID-19.